Investors are on the edge of our seats for the most anticipated week yet for EKNL. Dr. Paul Ziemer, now director of EKNL, will be giving an exclusive interview this morning at 9am EST.
Belize City, Belize -- (SBWIRE) -- 10/15/2012 -- Publishers of daily penny stock newsletter xtremepicks (http://www.xtremepicks.com) looks at EKO International (EKNL:PINK)
Tune into STT Radio interview TODAY at 9am EST at http://www.stocktraderstalk.com/live
Dr. Ziemer will also be featured on Small Cap Voice on Tuesday – watch for additional details soon.
and of course investors can follow the play by play on xtremepicks New Social Media site – DoUKnow.com
Join xtremepicks exclusive Room and Live CHAT on douknow.com by clicking here
Last week’s solid performance on EKNL was just insane closing to end the week at a 52 week high of $0.3795 and is on a wicked tear towards xtremepicks $1.25 target level. No doubt investors are in for the biggest breakout week yet, and are on high news alert for MAJOR updates to be unleashed by the company.
The buzz has been insane over the weekend with huge amount of eyes focusing on EKNL’s next move, including some key institutional investors eying the $1.25 level as well as xtremepicks active European base who are very keen on EKNL’s potential.
EKNL’s HUGE close at $0.3795 up 26.50% on over 1 million shares traded making a new 52 week high triggered a bullish breakout that will shoot prices ‘sky high’
Investors are already seeing the impact of a super low active float of only 5.5 Million shares and no doubt the accumulation since xtremepicks alert at $0.04 put shares in super strong hands. With insiders not selling a single share for less than dollar land, and inventory close to being all dried up, investors are well on our way to our target price of $1.25
When xtremepicks MONSTER winner Fuse Science (DROP) reached these level it only took a small catalyst to breakout and hit price target of $1.25 (83,000%+) dead on. With MEGA news expected to be unleashed by EKNL over the next few day and 2 exclusive interview early next week, no doubt it will be the catalyst to push prices sky high.
About EKO International
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
About NeuroVasc Clinical Inc
NeuroVasc Clinical Inc. has brought a solution to the North American market place. The patented technology called FREMS is an FDA and Health Canada approved device that uses a patented electrical frequency and duty cycle to stimulate blood vessel re-growth and tissue regeneration in tissue that has compromised nerve and blood vessel function. The patient is treated 10 times once daily for 40 minutes and the effects on the tissue will last up to 18 month depending on the overall health of the patient. Thus this treatment becomes part of the maintenance of the lower limb for the diabetic patient as they age and will be a key player in the prevention of painful neuropathy and the development of dangerous wounds.
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)